Submission Of Certificate Under Regulation 40(9) Of SEBI (LODR) Regulations, 2015
Pursuant to the provisions of Regulation 40(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we submit herewith certificate received from M/s. Gajanan D. Athavale, Practicing Company Secretary, Mumbai for the half year ended 31st March, 2017. Kindly take the same on your record Statement Of Investor Complaint For The Quarter Ended March 31, 2017
The Company did not receive and investor complaint during the quarter ended March 31, 2017 Shareholding for the Period Ended March 31, 2017
Gufic Biosciences Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2017. For more details, kindly Click here Compliance Certificate - Regulation 7(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
As per the requirement of Regulation 7 (3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby confirm that activities in relation to both physical and electronic share transfer facility are maintained during the period October 1, 2016 to March 31, 2017 (both days inclusive) by the Company's Registrar and Share Transfer Agent, viz., Link Intime India Private Limited, which is registered as Registrar & Share... Board Meeting On Monday April 03, 2017
To consider amalgamation of M/s. Gufic Lifesciences Private Limited, a company registered under Companies Act, 1956 with M/s. Gufic Biosciences Limited. Revised Financial Results for December 31, 2016
Gufic Biosciences Ltd has submitted to BSE a copy of Revised Financial Results for the period ended December 31, 2016. Standalone Financial Results, Limited Review Report for December 31, 2016
Gufic Biosciences Ltd has informed BSE about : 1. Standalone Financial Results for the period ended December 31, 20162. Standalone Limited Review for the period ended December 31, 2016 Revised - Board Meeting Intimation for Results & Closure of Trading Window
Gufic Biosciences Ltd has informed BSE regarding "Revised - Board Meeting Intimation for Results & Closure of Trading Window ". Board Meeting Intimation for Results & Closure of Trading Window
Gufic Biosciences Ltd has informed BSE that a meeting of the Board of Directors of the Company is scheduled to be held on February 14, 2017, inter alia, to consider and approve the Unaudited Financial Results of the Company for the quarter and nine months ended December 31, 2016.Further, pursuant to the provisions of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 and as per the terms of "Code of...